Now this is gettin' after it. I love it. Aggressiv
Post# of 7805
BioElectronics is working to accommodate additional orders after strong product launches in Q1 2021 by their three major channel partners: KT Health, Scott Specialties in the OTC space, AND Medi-Launch in the prescription medical market. Consumer acceptance of the technology has been very positive, as witnessed by strong consumer reviews for the KT Recovery+ Wave™ & DonJoy® EME powered by ActiPatch® (averaging over 4.5/5 on Amazon.com and their respective company websites). Feedback from surgeons for the RecoveryRx has been excellent.
Now what I find interesting is it says "... is working to accommodate additional orders ..." and in the same sentence mentions "... Medi-Launch in the prescription med market ...".
Sooooo ... has our Biel succeeded in making it onto the prescription market? Has my personal obsession w/ insurance become a reality? If yes, w/ whom? And with RecoveryRx? Have orders been accepted and in the process of being produced? Delivery times w/in the next 2-3 months? Does this explain the 5 & 100 packs? Has the production of all the required devices necessitated the 6+ month silence and not negotiations themselves?
I look forward to the 'official' monday release and what it does to the recent sell-off. The paragraph I have highlighted says a lot. Only time will tell the full ramifications but I can't help but feel there is much to be uncovered between the lines than the words themselves are saying.
take care, WBeacham